Prospera Financial Services Inc

Position in REGN — Regeneron Pharmaceuticals, Inc.

CIK 1541625 Dallas, TX

Position in REGN

as of Jun 30, 2026 · filed Jul 15, 2026 Compact

Position Value

$2,564,620

-$1,041,290 QoQ

Shares Held

4,113

-11.9% QoQ

Ownership

0.004%

of shares outstanding

% of Portfolio

0.06%

of 13F equity value

Holder Rank

#484

of 1,322 holders

Holding Since

Mar 2020

14 quarters on record

Voting authority Sole 0% Shared 0% None 100%

Healthcare · as of Jun 30, 2026

Prospera Financial Services Inc holds $8,455,010 across 19 Biotechnology names. REGN ranks #1 (30.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	REGN	Regeneron Pharmaceuticals, Inc. This page	4,113	$2,564,620
2	PBYI	Puma Biotechnology, Inc.	158,762	$1,287,559
3	VRTX	Vertex Pharmaceuticals Inc / Ma	2,571	$1,277,092
4	TGTX	Tg Therapeutics, Inc.	12,625	$693,617
5	VKTX	Viking Therapeutics, Inc.	9,781	$381,556
6	IONS	Ionis Pharmaceuticals Inc	4,194	$332,542
7	SRPT	Sarepta Therapeutics, Inc.	17,042	$306,244
8	SLS	SELLAS Life Sciences Group, Inc.	18,119	$267,436

14 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$2,564,620	4,113	-11.9%	Shares	Sole	2026-07-15
2026-03-31	$3,605,910	4,667	+2.5%	Shares	Sole	2026-04-14
2025-12-31	$3,513,552	4,552	-48.1%	Shares	Sole	2026-02-09
2025-09-30	$4,928,858	8,766	-38.0%	Shares	Sole	2025-11-06
2025-06-30	$7,419,825	14,133	+270.7%	Shares	Sole	2025-08-06
2025-03-31	$2,418,318	3,813	+3.1%	Shares	Sole	2025-05-15
2024-12-31	$2,634,196	3,698	+399.7%	Shares	Sole	2025-02-13
2024-09-30	$777,917	740	+23.3%	Shares	Sole	2024-11-07
2022-12-31	$432,894	600	+757.1%	Shares	Sole	2023-02-08
2022-06-30	$41,379	70	+2.9%	Shares	Sole	2022-08-08
2022-03-31	$47,492	68	-51.8%	Shares	Sole	2022-05-04
2020-09-30	$78,928	141	-90.0%	Shares	Sole	2020-11-04
2020-06-30	$874,980	1,403	-30.8%	Shares	Sole	2020-08-10
2020-03-31	$989,763	2,027	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.